Evaluation of the efficacy and tolerance of a throat spray based on essential oil of Cymbopogon giganteus

Not Applicable

• Conditions: Sore throat; Signs and Symptoms

• Registration Number: ISRCTN10896729
• Lead Sponsor: fr Pharmacie/ Faculte des Sciences de la Sante de Cotonou

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-11
• Last Update Posted: 20 March 2023
• Study Completion: 2023-08-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 137

Inclusion Criteria

1. 18 to 50 years
2. Sign the informed consent form
3. Sutpatient with sore throat with the 7 clinical signs : Throat pain in the oropharynx
Fever, Oropharyngeal redness, Oropharyngeal exudate, Tonsil hypertrophy, Lymphoid formation on posterior pharyngeal wall, Cervical lymphadenopathy

Exclusion Criteria

1. Having ongoing conventional treatment for angina
2. Having a known allergy to one of the constituents of the investigational product
3. Pregnant women
4. People with respiratory problems

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Clinical signs of sore throat at baseline and 3 days measured by the treating physician:<br> 1. Throat pain at the level of the oropharynx<br> 2. Fever<br> 3. Redness of the oropharynx<br> 4. Oropharyngeal exudate<br> 5. Hypertrophy of the tonsil<br> 6. Lymphoid formation on the pharyngo-posterior wall<br> 7. Cervical adenopathy<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Clinical signs of sore throat at 7 days measured by the treating physician<br> 2. Tolerance of the throat spray measured by patient report at 7 days<br>